Adar Poonawalla

in page functions

CEO & Executive Director, Serum Institute of India Ltd (SIIL), India

Adar Poonawalla

Adar Poonawalla is the CEO and Executive Director of Serum Institute of India Ltd (SIIL), one of the world’s largest vaccine manufacturers. Mr Poonawalla is also the Executive Director of Poonawalla Investments & Industries Pvt Ltd and Poonawalla Shares & Securities Ltd, and is a trustee of the Serum Institute of India Research Foundation, Jehangir Hospital and the Minoo Mehta Memorial Trust.

Under Mr Poonawalla’s stewardship, SIIL has helped grow vaccine manufacturing capacity to meet the rising global demand. He has not only been instrumental in getting new products licensed and prequalified by WHO but has also been actively involved in the research and development of new vaccines such as pneumococcal conjugate, rotavirus and HPV. In addition, SIIL has developed its own oral polio vaccine which will bridge the demand-supply gap for this vaccine. In a parallel development, the acquisition of Bilthoven Biologicals, a Netherlands-based government vaccine manufacturing company, will increase production of the new Inactivated Polio Vaccine (IPV) making it a viable option for more countries.

Mr Poonawalla has a degree in management from the University of Westminster (UK) and has completed further training in biotechnology and management in London (UK).

close icon

modal window here